Cetera Investment Advisers
DTIL icon

Cetera Investment Advisers’s Precision BioSciences DTIL Stock Holding History

Cetera Investment Advisers’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-379
Closed -$15K – 2127
2022
Q3 		$15K Sell
379
-300
-44% -$14.3K ﹤0.01% 1648
2022
Q2 		$33K Buy
679
+300
+79% +$17.6K ﹤0.01% 1787
2022
Q1 		$35K Sell
379
-41
-10% -$5.57K ﹤0.01% 1844
2021
Q4 		$93K Buy
420
+27
+7% +$7.54K ﹤0.01% 1800
2021
Q3 		$136K Sell
393
-300
-43% -$102K ﹤0.01% 1714
2021
Q2 		$260K Buy
693
+26
+4% +$7.81K ﹤0.01% 1506
2021
Q1 		$207K Buy
667
+103
+18% +$36.1K ﹤0.01% 1464
2020
Q4 		$141K Buy
564
+75
+15% +$18.4K ﹤0.01% 1498
2020
Q3 		$90K Buy
+489
New +$97.3K 0.01% 626

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cetera Investment Advisers's DTIL Position: Q4 2022 in Review

Cetera Investment Advisers sold out of Precision BioSciences (DTIL) in Q4 2022, closing a stake of 379 shares — an estimated $15K sold.

Cetera Investment Advisers first reported a position in DTIL in Q3 2020 and held it in 9 quarters. The position peaked at $260K in Q2 2021. 100 funds tracked by Wall St. Rank hold DTIL as of Q4 2022.

  • Cetera Investment Advisers reported no remaining Precision BioSciences position as of Q4 2022 after selling out during the quarter.
  • Cetera Investment Advisers sold 379 Precision BioSciences shares in Q4 2022, an estimated $15K.
  • Cetera Investment Advisers first reported a position in Precision BioSciences in Q3 2020 and held it in 9 quarters.
  • Cetera Investment Advisers's Precision BioSciences position peaked at $260K in Q2 2021.
  • 100 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2022.

Based on Cetera Investment Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.